Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
27.01
-2.48 (-8.41%)
At close: May 6, 2025, 4:00 PM
27.28
+0.27 (1.00%)
After-hours: May 6, 2025, 6:53 PM EDT
Viking Therapeutics Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Viking Therapeutics stock have an average target of 84, with a low estimate of 30 and a high estimate of 138. The average target predicts an increase of 211.00% from the current stock price of 27.01.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Viking Therapeutics stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 6 | 4 |
| Buy | 3 | 4 | 4 | 5 | 5 | 6 |
| Hold | 0 | 0 | 0 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 14 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $104 | Buy | Initiates | $104 | +285.04% | Apr 28, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $95 → $75 | Strong Buy | Reiterates | $95 → $75 | +177.67% | Apr 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $105 → $102 | Buy | Maintains | $105 → $102 | +277.64% | Apr 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $102 | Strong Buy | Reiterates | $102 | +277.64% | Apr 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $102 | Strong Buy | Reiterates | $102 | +277.64% | Apr 17, 2025 |
Financial Forecast
Revenue This Year
n/a
from 795.23M
Revenue Next Year
n/a
EPS This Year
-1.60
from -1.01
EPS Next Year
-2.16
from -1.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.3M | 97.9M | 292.9M | ||
| Avg | 1.5M | 6.6M | 40.6M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -96.7% | 6,424.0% | 4,351.3% | ||
| Avg | -99.8% | 338.6% | 517.1% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.03 | -1.45 | -0.83 | ||
| Avg | -1.60 | -2.16 | -2.51 | ||
| Low | -2.12 | -3.04 | -3.73 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.